Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future.

Saved in:
Bibliographic Details
Title: Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future.
Authors: Bursi R; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Cafaro G; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Perricone C; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Riccucci I; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Calvacchi S; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Gerli R; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Bartoloni E; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Mar 29; Vol. 12, pp. 635663. Date of Electronic Publication: 2021 Mar 29 (Print Publication: 2021).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2021.635663